Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Vycor Medical (VYCO) Other Operating Expenses (2016 - 2025)

Vycor Medical has reported Other Operating Expenses over the past 16 years, most recently at $14880.0 for Q4 2025.

  • Quarterly Other Operating Expenses changed 0.0% to $14880.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $59521.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $59521.0 for FY2025, 0.0% changed from the prior year.
  • Other Operating Expenses was $14880.0 for Q4 2025 at Vycor Medical, roughly flat from $14880.0 in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $17728.0 in Q3 2021 and troughed at $13945.0 in Q1 2021.
  • The 5-year median for Other Operating Expenses is $14880.0 (2024), against an average of $15042.0.
  • Year-over-year, Other Operating Expenses soared 31.74% in 2021 and then fell 17.88% in 2022.
  • A 5-year view of Other Operating Expenses shows it stood at $16795.0 in 2021, then fell by 14.41% to $14375.0 in 2022, then fell by 0.03% to $14371.0 in 2023, then increased by 3.54% to $14880.0 in 2024, then changed by 0.0% to $14880.0 in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Other Operating Expenses are $14880.0 (Q4 2025), $14880.0 (Q3 2025), and $14881.0 (Q2 2025).